批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/12/16 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:LISDEXAMFETAMINE DIMESYLATE 剂型/给药途径:TABLET, CHEWABLE;ORAL 规格:10MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
219258 |
001 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
10MG |
Prescription |
No |
No |
AB |
--
|
GRANULES |
208510 |
001 |
NDA |
VYVANSE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
10MG |
Prescription |
Yes |
No |
AB |
2017/01/28
|
TAKEDA PHARMS USA |
214134 |
001 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
10MG |
Prescription |
No |
No |
AB |
2023/08/25
|
SUN PHARM INDS INC |
215415 |
001 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
10MG |
Prescription |
No |
No |
AB |
2023/08/25
|
TEVA PHARMS |
217068 |
001 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
10MG |
Prescription |
No |
No |
AB |
2023/08/25
|
ASCENT PHARMS INC |
218306 |
001 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
10MG |
Prescription |
No |
No |
AB |
2024/02/02
|
MSN |
活性成分:LISDEXAMFETAMINE DIMESYLATE 剂型/给药途径:TABLET, CHEWABLE;ORAL 规格:20MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
219258 |
002 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
20MG |
Prescription |
No |
No |
AB |
--
|
GRANULES |
208510 |
002 |
NDA |
VYVANSE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
20MG |
Prescription |
Yes |
No |
AB |
2017/01/28
|
TAKEDA PHARMS USA |
214134 |
002 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
20MG |
Prescription |
No |
No |
AB |
2023/08/25
|
SUN PHARM INDS INC |
215415 |
002 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
20MG |
Prescription |
No |
No |
AB |
2023/08/25
|
TEVA PHARMS |
217068 |
002 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
20MG |
Prescription |
No |
No |
AB |
2023/08/25
|
ASCENT PHARMS INC |
218306 |
002 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
20MG |
Prescription |
No |
No |
AB |
2024/02/02
|
MSN |
活性成分:LISDEXAMFETAMINE DIMESYLATE 剂型/给药途径:TABLET, CHEWABLE;ORAL 规格:30MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
219258 |
003 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
30MG |
Prescription |
No |
No |
AB |
--
|
GRANULES |
208510 |
003 |
NDA |
VYVANSE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
30MG |
Prescription |
Yes |
No |
AB |
2017/01/28
|
TAKEDA PHARMS USA |
214134 |
003 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
30MG |
Prescription |
No |
No |
AB |
2023/08/25
|
SUN PHARM INDS INC |
215415 |
003 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
30MG |
Prescription |
No |
No |
AB |
2023/08/25
|
TEVA PHARMS |
217068 |
003 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
30MG |
Prescription |
No |
No |
AB |
2023/08/25
|
ASCENT PHARMS INC |
218306 |
003 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
30MG |
Prescription |
No |
No |
AB |
2024/02/02
|
MSN |
活性成分:LISDEXAMFETAMINE DIMESYLATE 剂型/给药途径:TABLET, CHEWABLE;ORAL 规格:40MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
219258 |
004 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
40MG |
Prescription |
No |
No |
AB |
--
|
GRANULES |
208510 |
004 |
NDA |
VYVANSE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
40MG |
Prescription |
Yes |
No |
AB |
2017/01/28
|
TAKEDA PHARMS USA |
214134 |
004 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
40MG |
Prescription |
No |
No |
AB |
2023/08/25
|
SUN PHARM INDS INC |
215415 |
004 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
40MG |
Prescription |
No |
No |
AB |
2023/08/25
|
TEVA PHARMS |
217068 |
004 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
40MG |
Prescription |
No |
No |
AB |
2023/08/25
|
ASCENT PHARMS INC |
218306 |
004 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
40MG |
Prescription |
No |
No |
AB |
2024/02/02
|
MSN |
活性成分:LISDEXAMFETAMINE DIMESYLATE 剂型/给药途径:TABLET, CHEWABLE;ORAL 规格:50MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
219258 |
005 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
50MG |
Prescription |
No |
No |
AB |
--
|
GRANULES |
208510 |
005 |
NDA |
VYVANSE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
50MG |
Prescription |
Yes |
No |
AB |
2017/01/28
|
TAKEDA PHARMS USA |
214134 |
005 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
50MG |
Prescription |
No |
No |
AB |
2023/08/25
|
SUN PHARM INDS INC |
215415 |
005 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
50MG |
Prescription |
No |
No |
AB |
2023/08/25
|
TEVA PHARMS |
217068 |
005 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
50MG |
Prescription |
No |
No |
AB |
2023/08/25
|
ASCENT PHARMS INC |
218306 |
005 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
50MG |
Prescription |
No |
No |
AB |
2024/02/02
|
MSN |
活性成分:LISDEXAMFETAMINE DIMESYLATE 剂型/给药途径:TABLET, CHEWABLE;ORAL 规格:60MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
219258 |
006 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
60MG |
Prescription |
No |
No |
AB |
--
|
GRANULES |
208510 |
006 |
NDA |
VYVANSE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
60MG |
Prescription |
Yes |
Yes |
AB |
2017/01/28
|
TAKEDA PHARMS USA |
214134 |
006 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
60MG |
Prescription |
No |
No |
AB |
2023/08/25
|
SUN PHARM INDS INC |
215415 |
006 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
60MG |
Prescription |
No |
No |
AB |
2023/08/25
|
TEVA PHARMS |
217068 |
006 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
60MG |
Prescription |
No |
No |
AB |
2023/08/25
|
ASCENT PHARMS INC |
218306 |
006 |
ANDA |
LISDEXAMFETAMINE DIMESYLATE |
LISDEXAMFETAMINE DIMESYLATE |
TABLET, CHEWABLE;ORAL |
60MG |
Prescription |
No |
No |
AB |
2024/02/02
|
MSN |